The diagnostic use of cytogenetic and molecular genetic techniques in the assessment of small round cell tumours

Current Diagnostic Pathology

Volumn 8, Issue 5, 2002, Pages 338-348

  Tarkkanen, M ^a   Knuutila, S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cutaneous neuroendocrine carcinoma; Desmoplastic small round cell tumour; Ewing's sarcoma; Lymphoma; Mesenchymal chondrosarcoma; Neuroblastoma; Review; Rhabdomyosarcoma; Small cell carcinoma; Small cell melanoma; Small cell osteosarcoma; Small round cell tumour

Indexed keywords

CANCER DIAGNOSIS; CHONDROSARCOMA; CYTOGENETICS; DESMOPLASTIC SMALL ROUND CELL TUMOR; DIFFERENTIAL DIAGNOSIS; ESTHESIONEUROBLASTOMA; EWING SARCOMA; HISTOPATHOLOGY; MELANOMA; MERKEL CELL TUMOR; MOLECULAR GENETICS; NEUROBLASTOMA; PROGNOSIS; REVIEW; RHABDOMYOSARCOMA; SMALL CELL CARCINOMA; SMALL CELL SARCOMA;

EID: 0036773024     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-6053(02)90135-3     Document Type: Review

References (90)

1. Devoe K, Weidner N. Immunohistochemistry of small round-cell tumors. Semin Diagn Pathol 2000; 17: 216-224.
2. Kumar S, Pack S, Kumar D et al. Detection of EWS-FLI-I fusion in Ewing's sarcoma/peripheral primitive neuroectodermal tumor by fluorescence in situ hybridization using formalin-fixed paraffinembedded tissue. Hum Pathol 1999; 30: 324-330.
3. Kallioniemi A, Kallioniemi O-P, Sudar D et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258: 818-821.
4. Visakorpi T, Hyytinen E, Koivisto P et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 1995; 9: 401-406.
5. Hemminki A, Tomlinson I, Markie D et al. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 1997; 15: 87-90.
6. Kallioniemi O-P, Kallioniemi A, Piper J et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994; 10: 231-243.
7. Bentz M, Plesch A, Stilgenbauer S, Döhner H, Lichter P. Minimal sizes of deletions detected by comparative genomic hybridization. Genes Chromosomes Cancer 1998; 21: 172-175.
8. Kallioniemi A, Kallioniemi O-P, Piper J et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 1994; 91: 2156-2160.
9. Peter M, Gilbert E, Delattre O. A multiplex real-time pcr assay for the detection of gene fusions observed in solid tumors. Lab Invest 2001; 81: 905-912.
10. Nielsen T O, West R B, Linn S C et al. Molecular characterisation of soft tissue tumours: A gene expression study. Lancet 2002; 359: 1301-1307.
11. Khan J, Wei J S, Ringner M et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001; 7: 673-679.
12. Winters J L, Geil J D, O'Connor W N. Immunohistology, cytogenetics, and molecular studies of small round cell tumors of childhood. Ann Clin Lab Sci 1995; 25: 66-78.
13. Ambros I M, Ambros P F, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Cancer 1991; 67: 1886-1893.
14. Delattre O, Zucman J, Melot T et al. The Ewing family of tumors - A subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994; 331: 294-299.
15. Aurias A, Rimbaut C, Buffe D, Dubousset J, Mazabraud A. Chromosomal translocations in Ewing's sarcoma. N Engl J Med 1983; 309: 496-497.
16. Turc-Carel C, Philip I, Berger M-P, Philip T, Lenoir G M. Chromosomal translocations in Ewing's sarcoma. N Engl J Med 1983; 309: 497-498.
17. Mitelman F, Johansson B, Mertens F. Mitelman Database of Chromosome Aberrations in Cancer, http://cgap.nci.nih.gov/Chromosomes/Mitelman. 2002.
18. Delattre O, Zucman J, Plougastel B et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992; 359: 162-165.
19. Zucman J, Melot T, Desmaze C et al. Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 1993; 12: 4481-4487.
20. Jeon I-S, Davis N, Braun B S et al. A variant Ewing's sarcoma translocation t(7;22) fuses the EWS gene to the ETS gene ETVI. Oncogene 1995; 10: 1229-1234.
21. Kaneko Y, Yoshida K, Handa M et al. Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosomes Cancer 1996; 15: 115-121.
22. Peter M, Couturier J, Pacquement H et al. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 1997; 14: 1159-1164.
23. Ginsberg J P, de Alava E, Ladanyi M et al. EWS-FLII and EWSERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma. J Clin Oncol 1999; 17: 1809-1814.
24. de Alava E, Kawai A, Healey J H et al. EWS-FLII fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 1998; 16: 1248-1255.
25. Zoubek A, Dockhorn-Dworniczak B, Delattre O et al. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 1996; 14: 1245-1251.
26. Armengol G, Tarkkanen M, Virolainen M et al. Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridisation. Br J Cancer 1997; 75: 1403-1409.
27. Douglass E C, Rowe S T, Valentine M, Parham D, Meyer W H, Thompson E I. A second nonrandom translocation, der(16)t(1;16)(q21;q13), in Ewing sarcoma and peripheral neuroectodermal tumor. Cytogenet Cell Genet 1990; 53: 87-90.
28. Hattinger C M, Rumpler S, Strehl S et al. Prognostic impact of deletions at Ip36 and numerical aberrations in Ewing tumors. Genes Chromosomes Cancer 1999; 24: 243-254.
29. Kullendorff C M, Mertens F, Donner M, Wiebe T, Åkerman M, Mandahl N. Cytogenetic aberrations in Ewing sarcoma: Are secondary changes associated with clinical outcome? Med Pediatr Oncol 1999; 32: 79-83.
30. Maurici D, Perez-Atayde A, Grier H E, Baldini N, Serra M, Fletcher J A. Frequency and implication of chromosome 8 and 12 gains in Ewing's sarcoma. Cancer Genet Cytogenet 1998; 100: 106-110.
31. Mugneret F, Lizard S, Aurias A, Turc-Carel C. Chromosomes in Ewing's sarcoma. II. Nonrandom additional changes, trisomy 8 and der(16)t(1;16). Cancer Genet Cytogenet 1988; 32: 239-245.
32. Tarkkanen M, Kiuru-Kuhlefelt S, Blomqvist C et al. Clinical correlations of genetic changes by comparative genomic hybridization in Ewing tumors. Cancer Genet Cytogenet 1999; 114: 35-41.
33. Hattinger C, Pötschger U, Tarkkanen M et al. Prognostic impact of chromosomal aberrations in Ewing tumors. Br J Cancer 2002; 86: 1763-1769.
34. Noguera R, Navarro S, Triche T J. Translocation (11;22) in small cell osteosarcoma. Cancer Genet Cytogenet 1990; 45: 121-124.
35. Burchill S A, Wheeldon J, Cullinane C, Lewis I J. EWS-FLII fusion transcripts identified in patients with typical neuroblastoma. Eur J Cancer 1997; 33: 239-243.
36. Sainati L, Scapinello A, Montaldi A et al. A mesenchymal chondrosarcoma of a child with the reciprocal translocation (11;22)(q24;q 12). Cancer Genet Cytogenet 1993; 71: 144-147.
37. Thorner P, Squire J, Chilton-MacNeil S et al. Is the EWS/FLI- I fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types. Am J Pathol 1996; 148: 1125-1138.
38. Ordi J, de Alava E, Torne A et al. Intraabdominal desmoplastic small round cell tumor with EWS/ERG fusion transcript. Am J Surg Pathol 1998; 22: 1026-1032.
39. Rosoff P M, Hatcher S, West D C. Biphenotypic sarcoma with characteristics of both a Ewing sarcoma and a desmoplastic small round cell tumor. Med Pediatr Oncol 2000; 34: 407-412.
40. Katz R L, Quezado M, Senderowicz A M, Villalba L, Laskin W B, Tsokos M. An intra-abdominal small round cell neoplasm with features of primitive neuroectodermal and desmoplastic round cell tumor and a EWS/FLI-I fusion transcript. Hum Pathol 1997; 28: 502-509.
41. Huvos A G. Osteogenic sarcoma. In: Bone Tumors. Diagnosis, Treatment and Prognosis, 2nd Edn. Philadelphia: W. B. Saunders, 1991; 85-155.
42. Boehm A K, Neff J R, Squire J A, Bayani J, Nelson M, Bridge J A. Cytogenetic findings in 36 osteosarcoma specimens and a review of the literature. Pediatr Pathol Mol Med 2000; 19: 359-376.
43. Nakashima Y, Park Y-K. Mesenchymal chondrosarcoma. In: Fletcher C D, Unni K, Mertens F (eds). Pathology and Genetics of Tumours of Soft Tissue and Bone. In: Kleihues P, Sobin L (eds). WHO Classification of Tumors. IARC, 2002, in press.
44. Gerald W L, Ladanyi M, de Alava E et al. Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): Desmoplastic small round-cell tumor and its variants. J Clin Oncol 1998; 16: 3028-3036.
45. Gerald W L, Miller H K, Battifora H, Miettinen M, Silva E G, Rosai J. Intra-abdominal desmoplastic small round-cell tumor. Am J Surg Pathol 1991; 15: 499-513.
46. Sawyer J R, Tryka A F, Lewis J M. A novel reciprocal chromosome translocation t(11;22)(p13;q12) in an intraabdominal desmoplastic small round-cell tumor. Am J Surg Pathol 1992; 16: 411-416.
47. Ladanyi M, Gerald W. Fusion of the EWS and WTI genes in the desmoplastic small round cell tumor. Cancer Res 1994; 54: 2837-2840.
48. Douglass E C, Valentine M, Etcubanas E, Parham D, Webber B L, Houghton P J. A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet 1987; 45: 148-155.
49. Galili N, Davis R J, Fredericks W J et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet 1993; 5: 230-235.
50. Shapiro D N, Sublett J E, Li B, Downing J R, Naeve C W. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 1993; 53: 5108-5112.
51. Biegel J A, Meek R S, Parmiter A H, Conard K, Emanuel B S. Chromosomal translocation t(1;13)(p36;q14) in a case of rhabdomyosarcoma. Genes Chromosomes Cancer 1991; 3: 483-484.
52. Douglass E C, Rowe S T, Valentine M et al. Variant translocations of chromosome 13 in alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 1991; 3: 480-482.
53. Davis R J, D'Cruz C M, Lovell M A, Biegel J A, Barr F G. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 1994; 54; 2869-2872.
54. Gordon A T, Brinkschmidt C, Anderson J et al. A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 2000; 28: 220-226.
55. Pandita A, Zielenska M, Thorner P et al. Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma. Neoplasia 1999; 1: 262-275.
56. Hachitanda Y, Toyoshima S, Akazawa K, Tsuneyoshi M. N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: Its correlation with histologic features. Mod Pathol 1998; 11: 1222-1227.
57. Scrable H J, Witte D P, Lampkin B C, Cavenee W K. Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature 1987; 329: 645-647.
58. Sabbioni S, Barbanti-Brodano G, Croce C M, Negrini M. GOK: A gene at 11p15 involved in rhabdomyosarcoma and rhabdoid tumor development. Cancer Res 1997; 57: 4493-4497.
59. Schwienbacher C, Sabbioni S, Campi M et al. Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWRIA gene reveals the presence of mutations in tumor samples. Proc Natl Acad Sci USA 1998; 95: 3873-3878.
60. Weber-Hall S, Anderson J, McManus A et al. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res 1996; 56: 3220-3224.
61. Bridge J A, Liu J, Weibolt V et al. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: An intergroup rhabdomyosarcoma study. Genes Chromosomes Cancer 2000; 27: 337-344.
62. Alexander F. Neuroblastoma. Urol Clin North Am 2000; 27: 383-392.
63. White P S, Maris J M, Beltinger C et al. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 1995; 92: 5520-5524.
64. Schwab M, Alitalo K, Klempnauer K-H et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature 1983; 305: 245-248.
65. Brodeur G M, Nakagawara A. Molecular basis of clinical heterogeneity in neuroblastoma. Am J Pediatr Hematol Oncol 1992; 14: 111-116.
66. Meddeb M, Danglot G, Chudoba I et al. Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas. Genes Chromosomes Cancer 1996; 17: 156-165.
67. Bown N, Cotterill S, Lastowska M et al. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. New Engl J Med 1999; 340: 1954-1961.
68. Gilbert J, Haber M, Bordow S B, Marshall G M, Norris M D. Use of tumor-specific gene expression for the differential diagnosis of neuroblastoma from other pediatric small round-cell malignancies. Am J Pathol 1999; 155: 17-21.
69. Eden B V, Debo R F, Larner J M et al. Esthesioneuroblastoma. Long term outcome and patterns of failure - The University of Virginia experience. Cancer 1994; 73: 2556-2562.
70. Argani P, Perez-Ordonez B, Xiao H, Caruana S M, Huvos A G, Ladanyi M. Olfactory neuroblastoma is not related to the Ewing family of tumors: Absence of EWS/FLII gene fusion and MIC2 expression. Am J Surg Pathol 1998; 22: 391-398.
71. Jin Y, Mertens F, Arheden K et al. Karyotypic features of malignant tumors of the nasal cavity and paranasal sinuses. Int J Cancer 1995; 60: 637-641.
72. Mezzelani A, Tornielli S, Minoletti F, Pierotti M A, Sozzi G, Pilotti S. Esthesioneuroblastoma is not a member of the primitive peripheral neuroectodermal tumour-Ewing's group. Br J Cancer 1999; 81: 586-591.
73. Pellin A, Boix J, Blesa J R, Noguera R, Carda C, Llombart-Bosch A. EWS/FLI-I rearrangement in small round cell sarcomas of bone and soft tissue detected by reverse transcriptase polymerase chain reaction amplification. Eur J Cancer 1994; 30A: 827-831.
74. Leonard J H, Cook A L, Nancarrow D et al. Deletion mapping on the short arm of chromosome I in Merkel cell carcinoma. Cancer Detection Prev 2000; 24: 620-627.
75. Cook A L, Pollock P M, Welch J et al. CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine (Merkel cell) carcinoma of the skin. Int J Cancer 2001; 93: 361-367.
76. Van Gele M, Leonard J H, Van Roy N, Cook A L, De Paepe A, Speleman F. Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma. Int J Cancer 2001; 92: 409-413.
77. Leonard J H, Hayard N. Loss of heterozygosity of chromosome 13 in Merkel cell carcinoma. Genes Chromosomes Cancer 1997; 20: 93-97.
78. Gancberg D, Feoli F, Hamels J et al. Trisomy 6 in Merkel cell carcinoma: A recurrent chromosomal aberration. Histopathology 2000; 37: 445-451.
79. Van Gele M, Speleman F, Vandesompele J, Van Roy N, Leonard J H. Characteristic pattern of chromosomal gains and losses in Merkel cell carcinoma detected by comparative genomic hybridization. Cancer Res 1998; 58: 1503-1508.
80. Sozzi G, Alder H, Tornielli S et al. Aberrant FHIT transcripts in Merkel cell carcinoma. Cancer Res 1996; 56: 2472-2474.
81. Wistuba I I, Gazdar A F, Minna J D. Molecular genetics of small cell lung carcinoma. Semin Oncol 2001; 28: 3-13.
82. Salgia R, Skarin A T. Molecular abnormalities in lung cancer. J Clin Oncol 1998; 16: 1207-1217.
83. Sorensen P H B, Lessnick S L, Lopez-Terrada D, Liu X F, Triche T J, Denny C T. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 1994; 6: 146-151.
84. Squire J, Zielenska M, Thorner P et al. Variant translocations of chromosome 22 in Ewing's sarcoma. Genes Chromosomes Cancer 1993; 8: 190-194.
85. Shen W P V, Towne B, Zadeh T M. Cytogenetic abnormalities in an intraabdominal desmoplastic small cell tumor. Cancer Genet Cytogenet 1992; 64: 189-191.
86. El-Kattan I, Redline R W, El-Naggar A K, Grimes M C, Abdul-Karim F W. Cytologic features of intraabdominal desmoplastic small round cell tumor. A case report. Acta Cytol 1995; 39: 514-520.
87. Roberts P, Burchill S A, Beddow R A, Wheeldon J, Cullinane C, Lewis I J. A combined cytogenetic and molecular approach to diagnosis in a case of desmoplastic small round cell tumor with a complex translocation (11;22;21). Cancer Genet Cytogenet 1999; 108: 19-25.
88. Vettenranta K, Aalto Y, Wikström S, Knuutila S, Saarinen-Pihkala U. Comparative genomic hybridization reveals changes in DNA-copy number in poor-risk neuroblastoma. Cancer Genet Cytogenet 2001; 125: 125-130.
89. Heim S, Mitelman F. Cancer Cytogenetics, 2nd Edn. New York: Wiley-Liss, Inc., 1995.
90. Zhu Y, Monni O, Franssila K et al. Deletions at 11q23 in different lymphoma subtypes. Haematologica 2000; 85: 908-912.